Overcoming resistance in Her2-positive metastatic breast cancer

被引：0
|
作者：
Oksuzoglu, Omur Berna [1 ,2 ]
机构：
[1] Erzincan Univ, Fac Med, Dept Internal Med, Med Oncol, Erzincan, Turkey
[2] A Yurtaslan Ankara Oncol Traning & Res Hosp, Dept Med Oncol, Ankara, Turkey
来源：
LEUKEMIA RESEARCH | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-22
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] Advanced HER2-positive breast cancer: Overcoming treatment resistance
    Rimawi, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Overcoming Treatment Resistance in HER2-Positive Breast Cancer Potential Strategies
    Puglisi, Fabio
    Minisini, Alessandro Marco
    De Angelis, Carmine
    Arpino, Grazia
    DRUGS, 2012, 72 (09) : 1175 - 1193
  • [3] HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance
    Pernas, Sonia
    Tolaney, Sara M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [4] Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy
    Derakhshani, Afshin
    Rezaei, Zohreh
    Safarpour, Hossein
    Sabri, Morteza
    Mir, Atefeh
    Sanati, Mohammad Amin
    Vahidian, Fatemeh
    Moghadam, Ali Gholamiyan
    Aghadoukht, Ali
    Hajiasgharzadeh, Khalil
    Baradaran, Behzad
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) : 3142 - 3156
  • [5] Updates in HER2-Positive Metastatic Breast Cancer
    Gadi, V. K.
    Iyengar, Neil
    Isaacs, Claudine
    Kaklamani, Virginia
    ONCOLOGY-NEW YORK, 2021, 35 (09): : 588 - 591
  • [6] Margetuximab in HER2-positive metastatic breast cancer
    Gradishar, William J.
    O'Regan, Ruth
    Rimawi, Mothaffar F.
    Nordstrom, Jeffrey L.
    Rosales, Minori K.
    Rugo, Hope S.
    FUTURE ONCOLOGY, 2023, 19 (16) : 1099 - 1112
  • [7] Therapy for HER2-Positive Metastatic Breast Cancer
    Dekker, Tim J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25):
  • [8] Overcoming Treatment Resistance in HER2-Positive Breast CancerPotential Strategies
    Fabio Puglisi
    Alessandro Marco Minisini
    Carmine De Angelis
    Grazia Arpino
    Drugs, 2012, 72 (9) : 1175 - 1193
  • [9] The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistance
    Zhang, Yuesheng
    PHARMACOLOGY & THERAPEUTICS, 2021, 218
  • [10] Treatment of HER2-Positive Metastatic Breast Cancer REPLY
    Swain, Sandra M.
    Clark, Emma
    Baselga, Jose
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20): : 1964 - 1965
12345